根据NRG GY018试验的结果,在不考虑PD-L1表达情况的子宫内膜癌患者中,与单独化疗相比,卡铂+紫杉醇(CP)化疗加用帕博利珠单抗显著改善了无进展生存期(PFS)。在2024 SGO会议上,加州大学圣地亚哥分校摩尔斯癌症中心Ramez N. Eskander也介绍了NR...
1.Eskander RN, Sill MW, Beffa L, et al. SEMINAL: Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: the phase 3, NRG GY018 study. 2023 Annual Global Meeting of theInternationalGynecologic Cancer So...
根据NRG GY018试验的结果,在不考虑PD-L1表达情况的子宫内膜癌患者中,与单独化疗相比,卡铂+紫杉醇(CP)化疗加用帕博利珠单抗显著改善了无进展生存期(PFS)。在2024 SGO会议上,加州大学圣地亚哥分校摩尔斯癌症中心Ramez N. Eskander也介绍了NRG GY018试验未成熟的总生存(OS)结果,即在错配修复(MMR)缺陷(dMMR)和MMR正...
For instance, although RTOG 0617 had heart dose recommendations, NRG-LU001 used specific heart constraints for several variables, including V30 (ie, the percentage of the heart receiving at least 30 Gy), which has recently been shown to be associated with OS in RTOG 0617.2 Although few acute...
Fractionated doses of external radiation are used to treat HNSCC (2 Gy per cycle to a total of 70 Gy) (Hutchinson et al., 2020). The total dose required for ef- fective treatment of malignancies with RIT is not well-defined (Macklis, 2004). Other factors such as the tumour growth ...
01月03日,俄罗斯对谷歌罚款已达位数美元,女教师三上悠亚ssni452,欧亚大观大鲁阁图片用户如何欣赏与解读大鲁阁艺术风,十种常见的男性玩坤巴的方法99健康网,《吴梦梦无套》BD中字无广告在线观看,《大象焦伊人在钱8》1797集免费在线播放,探究GY2022软件的独特特性——宏翔小蓝视频解析工具-,欧美VPSWINDOWS极品:...
根据NRG GY018试验的结果,在不考虑PD-L1表达情况的子宫内膜癌患者中,与单独化疗相比,卡铂+紫杉醇(CP)化疗加用帕博利珠单抗显著改善了无进展生存期(PFS)。在2024 SGO会议上,加州大学圣地亚哥分校摩尔斯癌症中心Ramez N. Eskander也介绍了NRG GY018试验未成熟的总生存(OS)结果,即在错配修复(MMR)缺陷(dMMR)和MMR正...
Experts on endometrial cancer review the NRG-GY018 and RUBY clinical trials. Video Player is loading. This is a modal window. This video is either unavailable or not supported in this browser Error Code: MEDIA_ERR_SRC_NOT_SUPPORTED Technical details : No compatible source was found for this...
Bhavana Pothuri, MD, discusses the promise of the phase 3 NRG-GY018 and RUBY trials in patients with endometrial cancer.